LCTX vs OMC · rev $2.8M vs rev $17.27B
Lineage Cell Therapeutics Inc (LCTX) versus Omnicom Group Inc (OMC) — a side-by-side from cached financials, not a winner call.
Lineage Cell Therapeutics Inc (LCTX) is a biotechnology company listed on US.
Omnicom Group Inc (OMC) is a advertising agencies company listed on NYSE.
Latest reported LCTX revenue for 2026-06-30 was $2.8M. Net income was -$3.3M. Revenue was up 62.0% from 2026-03-31 to 2026-06-30. LCTX currently screens at market cap $213.6M.
Latest reported OMC revenue for 2025-12-31 was $17.27B. Net income was -$54.5M. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. OMC currently screens at market cap $21.75B.
LCTX currently screens at market cap $213.6M. OMC currently screens at market cap $21.75B.
Not investment advice. Open the LCTX and OMC stock pages for the full models.
Not investment advice.